Literature DB >> 25209854

Concomitant accumulation of α-synuclein and TDP-43 in a patient with corticobasal degeneration.

Satoshi Yamashita1, Naomi Sakashita, Taro Yamashita, Nozomu Tawara, Masayoshi Tasaki, Kensuke Kawakami, Yoshihiro Komohara, Yukio Fujiwara, Masashi Kamikawa, Takenobu Nakagawa, Teruyuki Hirano, Yasushi Maeda, Masato Hasegawa, Motohiro Takeya, Yukio Ando.   

Abstract

Pathological changes in corticobasal degeneration (CBD) consist of abnormal deposition of the microtubule-associated protein tau. However, the simultaneous accumulation of different misfolded proteins in the brain can be observed in many neurodegenerative diseases with significantly longer disease durations. We encountered a patient with CBD who survived for an extremely long period (18 years) after the diagnosis. We performed an autopsy to elucidate the effect of the longer survival on the pathology of CBD. We observed abnormal aggregation of trans-activating response region DNA-binding protein of 43 kDa (TDP-43) and α-synuclein, as well as phosphorylated tau, in neurons of broader regions of the brain, beyond the amygdala and other limbic areas. We found that phosphorylated tau, α-synuclein, and TDP-43 partially co-existed in the same cellular aggregates. The triple pathologic changes might be related to the longer survival of the patient compared with the typical clinical course of patients with CBD. Further investigations are required to support the hypothesis that tauopathy, synucleinopathy, and TDP-43 proteinopathy might share common pathogenic mechanisms in terms of cross-seeding of the pathologic proteins.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25209854     DOI: 10.1007/s00415-014-7491-8

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  36 in total

1.  Neuropathological features of corticobasal degeneration presenting as corticobasal syndrome or Richardson syndrome.

Authors:  Naomi Kouri; Melissa E Murray; Anhar Hassan; Rosa Rademakers; Ryan J Uitti; Bradley F Boeve; Neill R Graff-Radford; Zbigniew K Wszolek; Irene Litvan; Keith A Josephs; Dennis W Dickson
Journal:  Brain       Date:  2011-09-20       Impact factor: 13.501

2.  Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementia.

Authors:  Jonathan Wills; Jessica Jones; Thomas Haggerty; Valeriy Duka; Jeffrey N Joyce; Anita Sidhu
Journal:  Exp Neurol       Date:  2010-06-28       Impact factor: 5.330

3.  Frequent coexistence of Lewy bodies and neurofibrillary tangles in the same neurons of patients with diffuse Lewy body disease.

Authors:  E Iseki; W Marui; K Kosaka; K Uéda
Journal:  Neurosci Lett       Date:  1999-04-09       Impact factor: 3.046

4.  Initiation and synergistic fibrillization of tau and alpha-synuclein.

Authors:  Benoit I Giasson; Mark S Forman; Makoto Higuchi; Lawrence I Golbe; Charles L Graves; Paul T Kotzbauer; John Q Trojanowski; Virginia M-Y Lee
Journal:  Science       Date:  2003-04-25       Impact factor: 47.728

5.  Mutant ubiquitin and p62 immunoreactivity in cases of combined multiple system atrophy and Alzheimer's disease.

Authors:  Beatrice Terni; María Jesús Rey; Susana Boluda; Benjamín Torrejón-Escribano; M Pujol Sabate; Matil Calopa; Fred W van Leeuwen; Isidro Ferrer
Journal:  Acta Neuropathol       Date:  2007-01-20       Impact factor: 17.088

6.  Molecular analysis and biochemical classification of TDP-43 proteinopathy.

Authors:  Hiroshi Tsuji; Tetsuaki Arai; Fuyuki Kametani; Takashi Nonaka; Makiko Yamashita; Masami Suzukake; Masato Hosokawa; Mari Yoshida; Hiroyuki Hatsuta; Masaki Takao; Yuko Saito; Shigeo Murayama; Haruhiko Akiyama; Masato Hasegawa; David M A Mann; Akira Tamaoka
Journal:  Brain       Date:  2012-10-03       Impact factor: 13.501

7.  Corticodentatonigral degeneration with neuronal achromasia.

Authors:  J J Rebeiz; E H Kolodny; E P Richardson
Journal:  Arch Neurol       Date:  1968-01

8.  Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies.

Authors:  Kunihiro Uryu; Hanae Nakashima-Yasuda; Mark S Forman; Linda K Kwong; Christopher M Clark; Murray Grossman; Bruce L Miller; Hans A Kretzschmar; Virginia M-Y Lee; John Q Trojanowski; Manuela Neumann
Journal:  J Neuropathol Exp Neurol       Date:  2008-06       Impact factor: 3.685

9.  Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes.

Authors:  C F Lippa; H Fujiwara; D M Mann; B Giasson; M Baba; M L Schmidt; L E Nee; B O'Connell; D A Pollen; P St George-Hyslop; B Ghetti; D Nochlin; T D Bird; N J Cairns; V M Lee; T Iwatsubo; J Q Trojanowski
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

10.  17q-linked frontotemporal dementia-amyotrophic lateral sclerosis without tau mutations with tau and alpha-synuclein inclusions.

Authors:  Kirk C Wilhelmsen; Mark S Forman; Howard J Rosen; Loren I Alving; Jill Goldman; Jennie Feiger; James V Lee; Samantha K Segall; Joel H Kramer; Catherine Lomen-Hoerth; Katherine P Rankin; Julene Johnson; Heidi S Feiler; Michael W Weiner; Virginia M-Y Lee; John Q Trojanowski; Bruce L Miller
Journal:  Arch Neurol       Date:  2004-03
View more
  7 in total

Review 1.  The Amygdala as a Locus of Pathologic Misfolding in Neurodegenerative Diseases.

Authors:  Peter T Nelson; Erin L Abner; Ela Patel; Sonya Anderson; Donna M Wilcock; Richard J Kryscio; Linda J Van Eldik; Gregory A Jicha; Zsombor Gal; Ruth S Nelson; Bela G Nelson; Jozsef Gal; Md Tofial Azam; David W Fardo; Matthew D Cykowski
Journal:  J Neuropathol Exp Neurol       Date:  2018-01-01       Impact factor: 3.685

Review 2.  Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update-I. Hypokinetic-rigid movement disorders.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2019-06-18       Impact factor: 3.575

3.  Efficient RT-QuIC seeding activity for α-synuclein in olfactory mucosa samples of patients with Parkinson's disease and multiple system atrophy.

Authors:  Chiara Maria Giulia De Luca; Antonio Emanuele Elia; Sara Maria Portaleone; Federico Angelo Cazzaniga; Martina Rossi; Edoardo Bistaffa; Elena De Cecco; Joanna Narkiewicz; Giulia Salzano; Olga Carletta; Luigi Romito; Grazia Devigili; Paola Soliveri; Pietro Tiraboschi; Giuseppe Legname; Fabrizio Tagliavini; Roberto Eleopra; Giorgio Giaccone; Fabio Moda
Journal:  Transl Neurodegener       Date:  2019-08-08       Impact factor: 8.014

4.  The Significance of Asymmetry in the Assessment of Brain Perfusion in Atypical Tauopathic Parkinsonian Syndromes.

Authors:  Piotr Alster; Natalia Madetko; Bartosz Migda; Michał Nieciecki; Michał Kutyłowski; Leszek Królicki; Andrzej Friedman
Journal:  Diagnostics (Basel)       Date:  2022-07-09

5.  Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutation.

Authors:  Aoife P Kiely; Helen Ling; Yasmine T Asi; Eleanna Kara; Christos Proukakis; Anthony H Schapira; Huw R Morris; Helen C Roberts; Steven Lubbe; Patricia Limousin; Patrick A Lewis; Andrew J Lees; Niall Quinn; John Hardy; Seth Love; Tamas Revesz; Henry Houlden; Janice L Holton
Journal:  Mol Neurodegener       Date:  2015-08-27       Impact factor: 14.195

Review 6.  The Synaptic Function of α-Synuclein.

Authors:  Jacqueline Burré
Journal:  J Parkinsons Dis       Date:  2015       Impact factor: 5.568

7.  Skin α-Synuclein Aggregation Seeding Activity as a Novel Biomarker for Parkinson Disease.

Authors:  Zerui Wang; Katelyn Becker; Vincenzo Donadio; Sandra Siedlak; Jue Yuan; Masih Rezaee; Alex Incensi; Anastasia Kuzkina; Christina D Orrú; Curtis Tatsuoka; Rocco Liguori; Steven A Gunzler; Byron Caughey; Maria E Jimenez-Capdeville; Xiongwei Zhu; Kathrin Doppler; Li Cui; Shu G Chen; Jiyan Ma; Wen-Quan Zou
Journal:  JAMA Neurol       Date:  2020-09-28       Impact factor: 18.302

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.